DDX5 promotes proliferation and tumorigenesis of non‐small‐cell lung cancer cells by activating β‐catenin signaling pathway

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|10|1303-1312

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.10, 2015-10, pp. : 1303-1312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Significant role of Psf3 expression in non‐small‐cell lung cancer

By  

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1625-1634

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐335 inhibited cell proliferation of lung cancer cells by target Tra2β

By  

Cancer Science, Vol. 109, Iss. 2, 2018-02 ,pp. : 289-296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic value of 18F‐fluoroazomycin arabinoside PET/CT in patients with advanced non‐small‐cell lung cancer

By  

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1554-1560

John Wiley & Sons Inc

Access to resources Recommend Favorite

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1202-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

By  

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1202-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite